Evidence map›Paper›PMID 36593510›Full record

ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2023

Immunomodulatory effects of probiotic supplementation in patients with asthma: a randomized, double-blind, placebo-controlled trial.

Sina Sadrifar, Tannaz Abbasi-Dokht, Sarvenaz Forouzandeh, Farhad Malek, Bahman Yousefi, Amir Salek Farrokhi, Jafar Karami, Rasoul Baharlou

Open access · goldAbstract read
In one paragraph

Article in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. ISME communications · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Research advance in correlation between childhood asthma and gut microbiota.Frontiers in cellular and infection microbiology · 2025
    Review
  9. Article
  10. Efficacy of probiotics as adjuvant therapy in bronchial asthma: a systematic review and meta-analysis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Review
  11. Article
  12. Gut Mycobiome and Asthma.Journal of fungi (Basel, Switzerland) · 2024
    Review
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sina SadrifarDepartment of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Tannaz Abbasi-DokhtDepartment of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Sarvenaz ForouzandehDepartment of Internal medicine, Kosar Hospital, Semnan University of Medical Sciences, Semnan, Iran.
Farhad MalekDepartment of Internal medicine, Kosar Hospital, Semnan University of Medical Sciences, Semnan, Iran.
Bahman YousefiDepartment of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Amir Salek FarrokhiDepartment of Immunology, Pasteur Institute, Tehran, Iran.
Jafar KaramiMolecular and Medicine Research Center, Khomein University of Medical Sciences, Khomein, Iran.
Rasoul BaharlouDepartment of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran. baharlour@gmail.com.ORCID http://orcid.org/0000-0002-4785-2759
Semnan University of Medical Sciences · IRImam Khomeini Hospital · IRPasteur Institute of Iran · IR

Funding

Semnan University of Medical Sciences and Health Services A-10-473-3
6 · The paper itself

Abstract

backgroundAsthma is considered to be a chronic inflammatory disorder of the airways. Probiotics are living microorganisms that are found in the human gut and have protective effects against a wide range of diseases such as allergies. The aim of this study was to investigate the improvement of clinical asthma symptoms and changes in the expression pattern of selective microRNAs in patients with asthma and the changes in IL-4 and IFN-γ plasma levels after receiving probiotics. MATERIALS AND

methodsThe present study was a randomized, double-blind, placebo-controlled trial that enrolled 40 asthmatic patients. They were treated with probiotics or placebo: 1 capsule/day for 8 weeks. Pulmonary function tests, IL-4 and IFN-γ levels, and expression of microRNAs were assessed at baseline and after treatment.

resultsThe results showed that the expression of miR-16, miR146-a and IL-4 levels in patients with asthma after receiving probiotic supplementation was significantly reduced and miR-133b expression was increased. In addition, pulmonary function tests showed a significant improvement in Forced Expiratory Volume in 1 s and Forced Vital Capacity after receiving probiotics.

conclusionIn our study, 8-week treatment with probiotic supplementation led to reduced Th2 cells-associated IL-4 and improved Forced Expiratory Volume and Forced Vital Capacity. It appears probiotics can be used in addition to common asthma treatments.

Indexed as

AsthmaIFN-γIL-4MicroRNAProbiotic

Identifiers

PMID36593510
PMCPMC9806812
OpenAlexW4313455130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.